Introduction
============

Caffeine (1,3,7-trimethylxanthine) is believed to be the most widely and frequently consumed psychoactive substance in the world and is a natural constituent of numerous available foods and beverages, such as coffee, tea, cocoa products, and cola products \[[@b1-jao-2019-00227]\]. Various hypotheses have been postulated for the mechanisms of action of caffeine, including blocking of adenosine receptors, mobilization of intracellular calcium, inhibition of phosphodiesterases, and binding of caffeine to benzodiazepine receptors \[[@b2-jao-2019-00227]\]. However, the chief effect of caffeine is the blocking of adenosine receptors \[[@b3-jao-2019-00227],[@b4-jao-2019-00227]\]. These properties allow caffeine to affect many human tissues, including those of the central nervous system, cardiovascular system, and both smooth and skeletal muscular systems \[[@b4-jao-2019-00227],[@b5-jao-2019-00227]\]. Additionally, several studies have suggested that some effects of caffeine could be due to its effects on formation and release of neurotransmitters \[[@b2-jao-2019-00227]\], for example, levels of neurotransmitters such as glutamate, serotonin, noradrenaline, acetylcholine, and dopamine change due to adenosine blockage \[[@b1-jao-2019-00227],[@b4-jao-2019-00227]\]. Adenosine not only acts as a neurotransmitter and neuromodulator, but is also a constituent of other important bioactive molecules including adenosine triphosphate, ribonucleic acid, and secondary messengers such as cyclic adenosine monophosphate \[[@b4-jao-2019-00227]\].

There is extensive literature examining the effects of caffeine on physiological, electrophysiological, and cognitive functions, and it is believed to influence mood and cognitive performance \[[@b1-jao-2019-00227],[@b3-jao-2019-00227],[@b4-jao-2019-00227]\]. However, there is limited research focusing on the effects of caffeine on the auditory and especially vestibular system. Previous studies have evaluated effects of caffeine on the organ of corti \[[@b6-jao-2019-00227]\], auditory-evoked potentials \[[@b7-jao-2019-00227]-[@b10-jao-2019-00227]\], and vestibular system \[[@b11-jao-2019-00227]-[@b16-jao-2019-00227]\]. They showed that caffeine significantly suppressed the compound action potential of the auditory nerve and summation potential at low intensity, and increased the N1 latency at high and low intensities \[[@b6-jao-2019-00227]\]. Additionally, caffeine reduced the distortion product otoacoustic emissions at low intensities and increased it at high intensities, leading to the shortening of the outer hair cells \[[@b6-jao-2019-00227]\].

In auditory brain stem evoked responses (ABRs), caffeine ingestion significantly reduced the absolute and inter-peak latencies \[[@b7-jao-2019-00227],[@b10-jao-2019-00227]\] and increased the amplitude of wave V \[[@b7-jao-2019-00227]\]. However, there are conflicting results from numerous studies with respect to upper level potentials. In different studies, caffeine invoked reduced P1 middle latency response \[[@b7-jao-2019-00227]\], reduced P300 latency and amplitude \[[@b8-jao-2019-00227]\], and increased P1, P2, and P3b amplitude without any effect on the latency \[[@b9-jao-2019-00227]\].

There are also few studies on the effect of caffeine on the vestibular system. There were no significant effects found in studies performed for tests of caloric \[[@b11-jao-2019-00227],[@b12-jao-2019-00227]\], posturography \[[@b13-jao-2019-00227]\], rotary chair \[[@b14-jao-2019-00227]\], and vestibular-evoked myogenic potentials (cVEMP) \[[@b12-jao-2019-00227],[@b15-jao-2019-00227],[@b16-jao-2019-00227]\]. However, studies wherein oculomotor tests were performed showed that caffeine treatment significantly reduced the saccadic eye movements of smooth pursuit in schizophrenic patients \[[@b17-jao-2019-00227]\]. McNerney, et al. \[[@b14-jao-2019-00227]\] also reported statistically significant differences in the results of several oculomotor tests after caffeine ingestion, including vertical saccades, horizontal saccades, and optokinetics. Furthermore, Pilli, et al. \[[@b18-jao-2019-00227]\] reported that caffeine could reduce the saccade latency significantly.

It has been hypothesized that caffeine causes an increase in the release of neurotransmitters, such as glutamate, by interacting with the adenosine receptors, thus improving the sensory perception of auditory stimuli after caffeine intake \[[@b7-jao-2019-00227]\]. This is important because adenosine is a constitutive metabolite of all cells and is present in both the auditory \[[@b19-jao-2019-00227]\] and vestibular systems \[[@b20-jao-2019-00227]\].

However, the effects of caffeine on auditory and vestibular systems is still under debate, and there are no placebo-based clinical trials evaluating its effect on these systems and specially evoked potentials. Therefore, the main purpose of this study was to evaluate the effects of caffeine on auditory- and vestibular-evoked potentials in a randomized, double blind, placebo-controlled trial. Since caffeine affects the central nervous system as well as neuromuscular function, and cVEMP is result of the coordination between sensory and neuromuscular functions, we aimed to assess the effects of caffeine on cVEMP and ABRs.

Subjects and Methods
====================

The present study was designed as a randomized, double blind, placebo-controlled, interventional study approved by the Ethics Committee of Tehran University of Medical Sciences with code of BP-QP-110-01.

Participants
------------

The study group recruited 40 individuals (20 males, 20 females) aged 18-25 years from the Rehabilitation Faculty of Tehran University of Medical Sciences, Tehran, Iran. Individuals with no history of neurologic, myogenic, balance and cervical disorders, ear diseases, psychiatric illness, and habitual smoking and drinking, as well as those consuming vestibulotoxic drugs, such as gentamycin and neomycin, were included. Additionally, to eliminate the effect of weight, body mass index of 18.5-24.9 kg/m^2^ was considered as an inclusion criterion. Moreover, individuals with low caffeine intake (\<200 mg/day of caffeine-containing substances) were eligible to participate in this study.

All participants were asked to abstain from caffeine-containing substances (tea, coffee, and cola) for at least 6 hours before the test. Informed consent was obtained from all participants. To assure the health of the auditory system, participants underwent otoscopy (Reister, Jungingen, Germany), immittance audiometry (Zodiac, Madsen Co., Taastrup, Denmark), and pure tone audiometry (AC40, Interacoustics Co., Middelfart, Denmark) examinations. The inclusion criteria were normal tympanogram (static compliance between 0.3-1.6, middle ear pressure between -100-+50), acoustic reflexes with thresholds between 70-100 decibels in hearing level (dB HL) in immittance audiometry, and air conduction and bone conduction thresholds of ≤15 dB in pure tone audiometry.

Experimental procedure
----------------------

Initially, the ABRs and cVEMP were recorded in all participants by the experimenter. The participants were then randomly assigned to one of two groups, and both participants and experimenter were blind to the group allotment. The caffeine and placebo allotment was written in 40 similar envelopes, and 3 mg/kg caffeine (n=20) and 0 mg/kg caffeine or placebo (n=20) were placed in a container by a research collaborator. The standard dose of caffeine used in most studies is 3 mg/kg. The participants chose one of the envelopes randomly and gave it to the collaborator without opening it, and were thus allotted to one of two groups: test group and placebo group. Following this, the body weights of participants were measured using a weighing scale. The collaborator measured the caffeine amount (Human Pharmaceutical, Roma, Italy) per kg of body weight using the analyzer research scale and dissolved it in 100 mL of water. Moreover, a little powdered milk and sugar were added to improve the flavor, and the powdered milk helped achieve similar appearance of the drinks in both groups. The used cups were disposable and non-transparent. The collaborator wrote the name of the participants and the weight of the materials in a separate list not accessible to the participants. Since caffeine reaches its highest concentration in blood plasma within 30-60 min of ingestion, the tests were repeated after about 40 min. In order to eliminate the order effect, the test was conducted randomly once for the right ear and once for the left ear.

Recording procedure
-------------------

The cVEMP was recorded with 500 hertz (Hz) tone burst stimuli (2-1-2 duration) using insert earphone, at a repetition rate of 5.1/s, intensity of 95 dB HL, 10-1,500 Hz band-pass filter, 100 stimuli, 5000X gain, and with the active surface electrode placed over the upper one-third of the sternocleidomastoid muscle, reference electrode over the upper sternum, and ground electrode on the forehead. P13 and N23 latency, P13-N23 amplitude, threshold, and asymmetric ratio (AR) parameters were recorded. For equal contraction of muscles on both sides, the feedback method was adopted. ABRs were recorded at a repetition rate of 9.1/s, with rarefaction click stimuli, intensity of 90 dB peSPL (peak sound pressure level), 100-3,000 Hz filter, with the active surface electrode placed over the stimulated ear, reference electrode on the forehead, and ground electrode over the contralateral ear. The skin electrode contact impedance was maintained at \<5 kΩ.

Statistical analysis
--------------------

The normality of variables was assessed using the Kolmogorov-Smirnov Goodness-of-Fit test. The significance level was set at *p*\<0.01 for ABR and *p*\<0.05 for cVEMP. Wilcoxon test and Mann-Whitney U tests were used for within-group and between-group comparisons, respectively.

Results
=======

This study included 40 individuals of both sexes with a mean age of 23 years. Statistical analysis during the pre-ingestion session revealed that all parameters of cVEMP (P13, N23 latency, P13-N23 amplitude, AR, and threshold) and ABRs (absolute I, III, V, I-III, III-V and I-V inter-peak latency, and V/I amplitude ratio) were homogenous in both groups, and there was no significant difference between the groups for any parameters (*p*\>0.05). There was no significant difference between both ears; hence, their results were combined. The relative changes in parameters of ABRs and cVEMP are presented in [Table 1](#t1-jao-2019-00227){ref-type="table"} and [2](#t2-jao-2019-00227){ref-type="table"}. Relative changes were calculated as the difference between the pre- and post-data, divided by the standard deviation of pre-data.

In ABRs, a significant reduction was found in the test group compared with placebo group in absolute latencies of I, III, and V and inter-peak latencies of III-V and I-V ([Table 1](#t1-jao-2019-00227){ref-type="table"}). The relative changes in absolute latencies of I, III, and V and inter-peak latencies of III-V and I-V are shown in [Table 1](#t1-jao-2019-00227){ref-type="table"}. They increased or remained unchanged in the placebo group, but decreased in the test group. In the placebo group, the latencies of wave I, III, and V were 2.47±0.14, 4.57±0.13, and 6.54±0.20 milliseconds (ms) before and 2.48±0.14, 4.66±0.14, and 6.54±0.20 ms after the intervention, respectively. In the test group, the latencies of I, III, and V were 2.51±0.16, 4.56±0.15, 6.53±0.21 ms before the intervention, respectively, and reduced to 2.46±0.16, 4.53±0.11, and 6.45±0.20 ms, respectively, after caffeine intake. The inter-peak latencies of III-V and I-V in the test group were 1.97±0.13 ms and 4.03±0.17 ms before the intervention, which decreased to 1.91±0.15 ms and 3.97±0.20 ms, respectively. However, in the placebo group, the latency of III-V (1.97±0.14 ms) remained unchanged, while the latency of I-V increased slightly (from 4.06±0.20 ms to 4.07±0.20 ms).

The latency of I-III did not show a significant difference between the groups, but showed a slight decrease in both groups. The latency of I-III before and after caffeine intake was 2.06±0.13 ms and 2.04±0.13 ms in the test group, and 2.09±0.15 ms and 2.08±0.13 ms in the placebo group, respectively. No significant difference was found between the groups for V/I amplitude of ABRs. V/I amplitude of ABRs increased in both groups, from 6.95 µv to 12.09 µv in the test group and from 5.22 µv to 6.30 µv in the placebo group.

[Fig. 1](#f1-jao-2019-00227){ref-type="fig"} and [2](#f2-jao-2019-00227){ref-type="fig"} illustrate the relative changes of absolute and inter-peak latencies in both groups. As shown, all absolute latencies of ABRs decreased in the test group and increased in the placebo group. In the test group, maximum decrease was observed in the absolute latencies of wave I and V and interpeak latency of III-V, and minimum decrease was noted in absolute latency of III and inter-peak latency of I-III.

No statistically significant differences were observed in any of the cVEMP parameters in the test group compared with the placebo group (*p*\>0.05). The mean P13-N23 amplitude of cVEMP increased in both groups. However, the difference between the groups was not statistically significant. The only considerable finding was the changes in P13-N23 amplitude that bordered the significance level (*p*=0.061). The mean P13-N23 amplitude in the test group was 172.02±103.42 µv during pre-ingestion session that increased to 197.74±101.27 µv after caffeine intake. However, the mean P13-N23 amplitude in the placebo group was 137.95±78.17 µv that increased slightly to 138.04±80.83 µv.

The P13 and N23 latency also increased slightly in the test group after caffeine ingestion. In the test group, the latency of P13 and N23 increased from 16.61±0.84 ms and 24.54±1.45 ms to 16.67±0.89 ms and 24.84±1.38 ms, respectively. In the placebo group, the latency of P13 increased from 16.91±1.69 ms to 16.92±1.56 ms, but that of N23 fell from 24.89±1.41 ms to 24.85±1.28 ms. The threshold of cVEMP showed a slight decrease in both groups.

Discussion
==========

In general, the findings showed a significant reduction in the absolute latencies of I, III, and V and in the inter-peak latencies of III-V and I-V of the ABRs. However, there was no significant difference noted in the parameters of cVEMP in the test group compared with the placebo group. There is limited research focusing on the effects of caffeine on ABRs and cVEMP.

Latency reduction results in ABR in the present study are concurrent with the study by Dixit, et al. \[[@b7-jao-2019-00227]\] and Shalini, et al. \[[@b10-jao-2019-00227]\]. Dixit, et al. \[[@b7-jao-2019-00227]\] observed significant reduction in absolute latencies of waves IV and V along with I-V inter-peak latency of ABRs. Although they found latency reduction in I-III and III-V waves, the changes were not statistically significant. This was probably because of the low sample size in both studies. However, in the study by Shalini, et al. \[[@b10-jao-2019-00227]\], all waves showed absolute and inter-peak latency reduction, but there was no control group. The findings on the latency reduction also concurred with the studies showing that caffeine decreased the reaction time \[[@b21-jao-2019-00227]-[@b24-jao-2019-00227]\]. Seidl, et al. \[[@b21-jao-2019-00227]\] found that the reaction time improved in response to target stimuli after administration of a drink containing caffeine.

In other evoked potentials, Deslandes, et al. \[[@b25-jao-2019-00227]\] found P300 latency reduction at the Fz electrode when the participants consumed caffeine. However, Barry, et al. \[[@b9-jao-2019-00227]\] showed that caffeine had no effect on P1, P2, and P3b latency, but a significant increase was observed in the amplitude of P1, P2, and P3b at a dose of 250 mg. In contrast, no significant increase in V/I amplitude of ABRs was found in the present study. In the study by Dixit, et al. \[[@b7-jao-2019-00227],[@b24-jao-2019-00227]\], a significant increase was detected in wave V amplitude of ABRs, while in wave I there was no significant increase. Amplitude rise after caffeine intake have been also reported for other evoked potentials such as event-related potentials \[[@b26-jao-2019-00227]\] and visual evoked potentials \[[@b27-jao-2019-00227]\]. In studies using visual-evoked potentials, 3 mg/kg caffeine increased the amplitude of P2 and n2b \[[@b27-jao-2019-00227]\]. Although in event related potentials studies, other factors such as higher levels of attention and arousal were triggered by caffeine, they were not comparable with subcortical responses such as ABRs. We analyzed amplitude ratio of V/I in the present study and not the absolute amplitude of waves, because amplitude is a variable parameter and amplitude ratio is a more suitable parameter than absolute amplitude, which has not been evaluated in other studies.

It is suggested that latency reduction is caused by a boost in information processing speed \[[@b27-jao-2019-00227]\]. Caffeine stimulates the central nervous system initially at the higher-level functions of the brain, including cognition, memory, attention, and concentration, where altering the peripheral motor responses results in ergogenic action. Caffeine acts mainly by blocking the adenosine receptors, which are responsible for the "fine-tuning" of the neuronal communication. The stimulatory effect of caffeine as represented by the shorter latencies could also represent the speed at which the sensory information is being transmitted to their respective cortices of sensory memory, a part of the brain's cognition \[[@b10-jao-2019-00227]\]. Additionally, it has been reported that caffeine can improve the performance in central auditory behavioral tasks \[[@b28-jao-2019-00227]\]. Accordingly, Taghavi, et al. \[[@b28-jao-2019-00227]\] evaluated the effects of short-term caffeine consumption on speech and sound reception in noise using the acceptable noise level test in healthy individuals. Speech perception in noise is one of the central auditory functions that depends on the interaction of sensory and cognitive processing. They found that the individuals tolerated higher levels of speech in noise \[[@b28-jao-2019-00227]\].

In the present study, no statistically significant difference was found in the parameters of cVEMPs in the test group compared with the placebo group. There is not enough information regarding the effects of caffeine on the vestibular system, particularly on cVEMPs. The absence of significant effect of caffeine on cVEMPs in this study is in agreement with previous studies on the effect of caffeine on vestibular system employing different techniques, especially cVEMPs. There were no significant effects reported in the studies wherein tests of caloric \[[@b11-jao-2019-00227],[@b12-jao-2019-00227]\], posturography \[[@b13-jao-2019-00227]\], rotary chair \[[@b14-jao-2019-00227]\], and cVEMP \[[@b12-jao-2019-00227],[@b15-jao-2019-00227],[@b16-jao-2019-00227]\] were performed. de Sousa and Suzuki \[[@b15-jao-2019-00227]\] administered 420 mg of caffeine, and the cVEMP parameters were compared before and after caffeine intake. No statistically significant difference was found in the test results before and after caffeine ingestion. Similarly, in the study by McNerney, et al. \[[@b12-jao-2019-00227]\], 30 young healthy participants were tested with and without the consumption of moderate amount of caffeine before undergoing caloric and cVEMP tests. The results revealed that a moderate amount of caffeine did not have a clinically significant effect on the results of caloric and cVEMP tests in young healthy adults. However, another study reported statistically significant differences in the results of several oculomotor tests after caffeine ingestion \[[@b14-jao-2019-00227]\].

de Sousa and Suzuki \[[@b15-jao-2019-00227]\] suggested that there is probably a negligible influence of adenosine receptors on the sacculocollic pathway, and further studies are necessary to clarify the distribution of these receptors in the peripheral vestibular pathway. Another probable cause is that the cVEMP is not sufficiently sensitive to caffeine effects. There are also differences in the auditory brain stem responses and cVEMP. Perhaps, the difference between the findings of ABRs and cVEMP studies is due to the wider normal range of latency for the cVEMP than ABRs, where ABRs are a completely neurologic response but cVEMP is a neurologic as well as myogenic response. Thus, ABRs could have higher sensitivity to the caffeine-induced changes as compared to cVEMP. It seems that the extent of caffeine effects on the various evoked potentials is presumably different, probably because caffeine has complex psychophysiological roles and there are evident differences in the body responses of individuals to caffeine.

The findings of the present study about the effects of caffeine on auditory and vestibular systems in particular could be affected by the low statistical power and the small sample size. Moreover, because caffeine dose-response curve is like an inverted "U", and it has different effects at different doses, further studies with larger sample size and higher doses are needed to evaluate the effects of caffeine on auditory and vestibular systems in particular.

In conclusion, it seems that the extent of caffeine's effects on various evoked potentials is different owing to the complex psychophysiological roles of caffeine and differences in the body responses of individuals evoked by it. Latency reduction in ABRs indicated that caffeine improved transmission in the central brain auditory pathways. However, different effects of caffeine on the auditory- and vestibular-evoked potentials are probably because of the different sensitivities of ABRs and cVEMP. To understand the effect of higher doses of caffeine on cVEMP and ABRs, further studies with a larger sample size are required.
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![The effects of caffeine and placebo on absolute latencies of auditory brain stem responses. Relative changes in the absolute latencies of all auditory brain stem responses waves were significantly greater in caffeine group compared with the placebo group (^\*^*p*\<0.010, ^†^*p*\<0.001).](jao-2019-00227f1){#f1-jao-2019-00227}

![The effects of caffeine and placebo on inter-peak latencies of auditory brain stem responses. Relative changes in the inter-peak latencies of III-V and I-V waves of auditory brain stem responses were significantly greater in caffeine group compared with the placebo group. No significant changes was seen in I-III inter-peak latency in caffeine group compared with the placebo group (^†^*p*\<0.001).](jao-2019-00227f2){#f2-jao-2019-00227}

###### 

Relative changes in parameters of auditory brainstem responses in the test group and placebo group

  Parameters           3 mg/kg caffeine group   Control group    *p* value
  -------------------- ------------------------ ---------------- ---------------------------------------------------------
  Absolute latency                                               
   I                   -0.01 (0.041)            0.004 (0.01)     0.004^[\*](#tfn1-jao-2019-00227){ref-type="table-fn"}^
   III                 -0.006 (0.017)           0.002 (0.007)    0.002^[\*](#tfn1-jao-2019-00227){ref-type="table-fn"}^
   V                   -0.01 (0.016)            0.0007 (0.008)   \<0.001^[†](#tfn2-jao-2019-00227){ref-type="table-fn"}^
  Inter-peak latency                                             
   I-III               -0.009 (0.084)           -0.004 (0.028)   0.215
   III-V               -0.03 (0.065)            0.008 (0.063)    \<0.001^[†](#tfn2-jao-2019-00227){ref-type="table-fn"}^
   I-V                 -0.01 (0.041)            0.002 (0.013)    \<0.001^[†](#tfn2-jao-2019-00227){ref-type="table-fn"}^
  Amplitude ratio                                                
   V/I                 0.74 (5.26)              0.20 (2.74)      0.718

Values are presented as mean (standard deviation) unless otherwise indicated.

*p*\<0.010,

*p*\<0.001.

###### 

Relative changes in the parameters of cervical vestibular-evoked myogenic potentials in the test group and placebo group

  Parameters         3 mg/kg caffeine group   Control group   p value
  ------------------ ------------------------ --------------- ---------
  Latency                                                     
   P13               0.005 (0.03)             0.001 (0.01)    0.695
   N23               0.008 (0.04)             -0.001 (0.02)   0.384
  Amplitude                                                   
   P13-N23           0.14 (0.54)              0.0006 (0.46)   0.061
  Asymmetric ratio   -1.33 (0.05)             -1.80 (0.03)    0.794
  Threshold          -0.014 (0.04)            -0.019 (0.04)   0.703

Values are presented as mean (standard deviation) unless otherwise indicated.
